Lexicon Pharmaceuticals, Inc. (LXRX) Balance Sheet
As of 2026-06-30 (10-Q), Lexicon Pharmaceuticals, Inc. (LXRX) reported total assets of $250.1M, total liabilities of $75.5M and shareholders' equity of $174.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $40.9M. Long-term debt: $51.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LXRXLexicon Pharmaceuticals, Inc.Follow LXRX — free
—
Price chart with a free account
- Market cap
- 631.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 186.3 | 30.4 | 37.5 | 137.3 | 203.0 | 46.6 | 61.7 | 80.4 | 36.1 | 126.3 | 64.1 | 46.3 | 22.5 | 66.7 | 34.3 | 40.9 | |
| Short-term investments | 95.4 | 192.8 | 91.6 | 202.1 | 318.4 | 299.9 | 249.1 | 79.7 | 235.5 | 26.0 | 22.7 | 92.0 | 147.6 | 171.3 | 61.9 | 149.7 | |
| Receivables | 0.4 | 1.4 | 0.8 | 1.0 | 0.9 | 7.5 | 4.8 | 5.9 | 56.5 | 0.4 | 0.0 | 0.0 | 1.0 | 3.5 | 2.4 | 1.6 | |
| Inventory | — | — | — | — | — | 0.0 | 1.9 | 4.7 | 4.2 | 0.0 | — | 0.0 | 0.4 | 0.2 | 0.3 | 1.2 | |
| Current assets | 285.8 | 230.9 | 134.6 | 369.0 | 532.4 | 357.9 | 322.0 | 173.3 | 337.8 | 157.7 | 88.9 | 140.9 | 176.5 | 246.2 | 101.9 | 196.6 | |
| Total assets | 430.5 | 371.8 | 274.2 | 471.4 | 652.0 | 475.6 | 436.5 | 284.1 | 417.7 | 203.8 | 136.9 | 194.3 | 229.4 | 298.4 | 185.0 | 250.1 | |
| Current liabilities | 21.4 | 18.3 | 19.3 | 45.0 | 123.0 | 164.6 | 105.5 | 36.8 | 65.3 | 46.8 | 22.1 | 23.2 | 31.5 | 45.2 | 20.9 | 14.7 | |
| Long-term debt | 23.5 | 21.9 | 20.2 | 87.5 | 101.0 | 85.2 | 231.6 | 243.9 | 234.2 | 0.0 | 0.0 | 48.6 | 99.5 | 100.3 | 49.4 | 51.4 | |
| Short-term debt | 1.4 | 1.6 | 1.7 | 20.2 | 2.0 | 16.3 | 14.1 | 1.1 | 11.0 | 11.6 | 0.0 | — | — | 0.0 | 4.6 | 0.0 | |
| Total liabilities | 132.9 | 105.1 | 104.0 | 187.4 | 366.1 | 318.2 | 368.3 | 310.5 | 300.6 | 47.4 | 23.3 | 77.2 | 136.3 | 152.5 | 77.4 | 75.5 | |
| Shareholders' equity | 297.6 | 266.7 | 170.2 | 284.0 | 286.0 | 167.5 | 68.3 | -26.4 | 117.1 | 156.4 | 113.6 | 117.1 | 93.1 | 146.0 | 107.5 | 174.5 |
USD millions · SEC XBRL
Lexicon Pharmaceuticals, Inc. — questions
- How much cash does Lexicon Pharmaceuticals, Inc. have?
- $40.9M in cash and cash equivalents as of 2026-06-30.
- How much debt does Lexicon Pharmaceuticals, Inc. have?
- $51.4M of long-term debt and $0 due within a year as of 2026-06-30.
- What are Lexicon Pharmaceuticals, Inc.'s total assets?
- $250.1M as of 2026-06-30.
- What is Lexicon Pharmaceuticals, Inc.'s shareholders' equity?
- $174.5M as of 2026-06-30.
Every figure on this page comes from Lexicon Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.